Capillary Tech. Q1 FY27 Earnings Call — Analysis (NSE: CAPILLARY)
Capillary Technologies delivered 43% YoY revenue growth to ₹256 Cr in Q1FY27 and expanded ARR past ₹1,000 Cr, while integrating SessionM at a net acquisition cost of ₹17 Cr and maintaining full-year beat expectations.
Result quality: poor — Slipped to loss. Management sentiment: optimistic.
The take
Q1FY27 Revenue ₹256 Cr ( +43% YoY ) . New guidance — FY27 fy27 consolidated revenue and e… ₹1,065 Cr revenue and ₹172 Cr EBITDA . New story: M&A as CAC Substitution and Margin Arbitrage .
Results
Revenue reached ₹256 Cr (+43% YoY, 17% organic), EBITDA grew 132% YoY to ₹44 Cr (17.2% margin), while reported PAT stood at -₹9.55 Cr due to a one-time subsidiary cyber-banking fraud loss (normalized PAT ₹25 Cr).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹256 Cr | +43% | yoy · Q1FY27 |
| Organic Revenue Growth | 17% | +17% | yoy · Q1FY27 · excluding inorganic acquisitions and 6% FX tailwind |
| EBITDA | ₹44 Cr | +132% | yoy · Q1FY27 |
| EBITDA Margin | 17.19% | +619bps | yoy · Q1FY27 · improved from ~11% in Q1FY26 |
| Reported PAT | -₹9.55 Cr | none · Q1FY27 · impacted by exceptional cyber fraud loss and deferred tax liability | |
| Normalized PAT | ₹25 Cr | +31.58% | sequential · Q1FY27 · vs ₹19 Cr in Q4FY26 |
| ARR | ₹1,026 Cr | +33.99% | point_in_time · Q1FY27 · Jun-26; up from ₹765 Cr in FY26 |
| TTM New ACV | ₹92 Cr | +75% | yoy · Q1FY27 · excluding one large healthcare customer baseline in prior year |
| Net Acquisition Cost - SessionM | ₹17 Cr | point_in_time · Q1FY27 · net of debt/balance sheet adjustments from $20M headline EV |
Guidance
Management reaffirmed expectations to beat FY27 guidance of ₹1,065 Cr in revenue and ₹172 Cr in EBITDA, targeting ~17% full-year organic revenue growth (~23% including FX).
What management committed to
- Capillary Technologies will beat FY27 revenue of ₹1,065 Cr and EBITDA of ₹172 Cr. — INR1,065 crores revenue and INR172 crores EBITDA, FY27
- Capillary Technologies expects full-year FY27 organic revenue growth of approximately 17% (23% including currency tailwind). — 17%-odd full-year organic growth (23% including currency), FY27
- The first [Kognitiv] customer will fully migrate to the Capillary platform on September 1, 2026. — September 1st, Q2FY27
- Capillary Technologies targets completing [Kognitiv] customer upgrades by latest September 2027. — latest September of next year, 2027, Q2FY28
- [Kognitiv] customer migrations will deliver an incremental ₹15 Cr to ₹20 Cr of EBITDA over the next year. — INR15 cores to INR20 crores of EBITDAs, FY28
- Capillary Technologies expects to save at least $6M to $8M in server costs on [SessionM] over the next 3-4 quarters. — $6-7-8 million, Q1FY28
- [SessionM] margins will expand from breakeven to ~15% within one year, and to 35%-40% over two years. — 15%-odd in a year, and then over another year 35%-40%, Q1FY29
- Full-year FY27 new ACV will grow by at least 30% to 40% over FY26. — at least 30%-40% more new ACV than last year, FY27
- ESOP expenses for FY27 will be approximately ₹12 Cr to ₹15 Cr and maintained at 1% to 2% of revenue. — INR12 crores to INR15 crores, FY27
Key themes
M&A margin turnaround and AI adoption
How the narrative shifted
- M&A as CAC Substitution and Margin Arbitrage: Management frames M&A as an inorganic customer acquisition channel, acquiring sticky enterprise contracts cheaply (0.1-0.5x sales) and migrating them onto Capillary's software stack to expand gross margins from 30% to 70%+.
- AI-Driven Product Expansion via aiRA: Capillary is leveraging its base as an enterprise system of record to upsell conversational analytics (aiRA) and action agents, driving higher win rates (>35%) and outcome-based pricing.
- Shift from Agency Models to Software: Enterprise loyalty programs are migrating from legacy services agencies and slow in-house setups to cloud-native platforms to achieve agility and sub-100ms response times.
- Operational Integration of SessionM: Acquisition of SessionM from Mastercard adds $32M ARR at low net cost (₹17 Cr), with immediate path to profitability via server rationalization before software migration.
- Enterprise AI Defense and Agentic Commerce: Management argues brand, analyst ratings, and Fortune 500 referenceability create high moats against AI-native startups, while agentic shopping will make loyalty mechanics more rational and tech-critical.
Operational commentary
- SessionM integration on track with all $32M ARR customer contracts agreeing to transition to Capillary paper; business generated ₹5-6 Cr free cash in its first two months.
- Completed acqui-hire tuck-in of CustomerGlu (rebranded as Experiences+), providing no-code mobile/web engagement front-ends to eliminate client IT dependency.
- aiRA (AI agent stack) reached $2.0-$2.5M in ARR run-rate with 26 live enterprise deployments and ~10 monetized paying clients.
- Kognitiv platform migration to start with first client going live on Capillary platform on September 1, 2026 using proprietary AI migration tooling.
- Reported an isolated cyber-banking fraud incident in a subsidiary; insurance claim process initiated with management confirming zero client or employee data compromise.
Analyst Q&A
Q. What is the timeline and margin trajectory for SessionM client migration?
Client platform migrations will not begin until late FY27/early FY28, but operational server cost optimization (bringing 50%+ server cost down) will save $6-8M and lift SessionM margins to 15% within a year, reaching 35-40% over two years.
Q. Can you provide details on the insurance recovery for the cyber fraud incident?
Insurance claims have been initiated and the event is covered, but exact quantum and timing of recovery remain under progress without clear visibility yet.
Q. Why did SessionM net acquisition price reduce to ₹17 Cr from initial headline estimates?
Headline EV was $20M, but deal terms allowed closing adjustments for net debt items across Mastercard/SessionM entities, settling the final net cash outflow to ~₹17 Cr with zero acquired debt.
Q. Will management raise full-year guidance given the Q1 outperformance?
Confirmed they will beat the ₹1,065 Cr revenue and ₹172 Cr EBITDA targets, but declined to quantify the formal revision until later quarters.
Research and educational content only. Not investment advice.